Nath Bio-Genes (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nath Bio-Genes has submitted its quarterly financial results for the three months ended December 31, 2025 to the NSE. The headline confirms only that the results have been filed and does not include specific figures such as revenue, profit after tax, or EBITDA. Investors will need to review the detailed financial results document or the company's investor presentation for actual numbers and segment performance. No comparison with prior periods or management commentary is available in this filing.
This is a routine regulatory filing with no immediate price-moving information disclosed in the headline itself. Shareholders should look at the full results document to assess the company's Q3 performance and any guidance.